PEMBROKE, Bermuda--(BUSINESS WIRE)--The Board of Directors of RenaissanceRe Holdings Ltd. (NYSE: RNR) (“RenaissanceRe” or the “Company”) announced today that Shyam Gidumal has been nominated to stand ...
"The curative potential for novel therapeutics remains in question. The reason is partly because the field does not have longitudinal data on the outcomes of these therapies."—Shyam A. Patel, MD, PhD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback